4-74770077-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001729.4(BTC):c.144C>A(p.Asp48Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000745 in 1,611,008 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001729.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BTC | NM_001729.4 | c.144C>A | p.Asp48Glu | missense_variant | 2/6 | ENST00000395743.8 | NP_001720.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BTC | ENST00000395743.8 | c.144C>A | p.Asp48Glu | missense_variant | 2/6 | 1 | NM_001729.4 | ENSP00000379092.3 | ||
BTC | ENST00000512743.1 | c.78C>A | p.Asp26Glu | missense_variant | 1/4 | 5 | ENSP00000421747.1 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 152068Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 248754Hom.: 0 AF XY: 0.00000744 AC XY: 1AN XY: 134428
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1458822Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 725702
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74412
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 11, 2024 | The c.144C>A (p.D48E) alteration is located in exon 2 (coding exon 2) of the BTC gene. This alteration results from a C to A substitution at nucleotide position 144, causing the aspartic acid (D) at amino acid position 48 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at